Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 680-686

  Harder, Bryan ^a   Jiang, Tao ^a   Wu, Tongde ^a   Tao, Shasha ^a   De La Vega, Montserrat Rojo ^a   Tian, Wang ^a   Chapman, Eli ^a   Zhang, Donna D ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chemoprevention chemoresistance; Hrd1; Kelch like ech associated protein 1 (Keap1); Nuclear factor erytheroid derived 2 like 2 (Nrf2); Reactive oxygen species (ROS); Ubiquitin proteasome system (UPS)

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEASOME; TRANSCRIPTION FACTOR NRF2; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; NFE2L2 PROTEIN, HUMAN; PROTEIN P21;

ARTICLE; CHEMICAL MODIFICATION; DRUG RESISTANCE; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; ANIMAL; AUTOPHAGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; OXIDATION REDUCTION REACTION;

RATTUS;

ANIMALS; AUTOPHAGY; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 84938694329     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150020     Document Type: Article

References (50)

1. Wasserman, W.W. and Fahl, W.E. (1997) Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U.S.A. 94, 5361-5366 CrossRef PubMed
2. Hayes, J.D., McMahon, M., Chowdhry, S. and Dinkova-Kostova, A.T. (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 13, 1713-1748 CrossRef PubMed
3. Malhotra, D., Portales-Casamar, E., Singh, A., Srivastava, S., Arenillas, D., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T.W., Wasserman, W.W. and Biswal, S. (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res. 38, 5718-5734 CrossRef PubMed
4. Kensler, T.W., Wakabayashi, N. and Biswal, S. (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116 CrossRef PubMed
5. Kensler, T.W. and Wakabayashi, N. (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis 31, 90-99 CrossRef PubMed
6. Jaramillo, M.C. and Zhang, D.D. (2013) The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 27, 2179-2191 CrossRef PubMed
7. Kundu, J.K. and Surh, Y.J. (2010) Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm. Res. 27, 999-1013 CrossRef PubMed
8. Cheung, K.L., Khor, T.O., Huang, M.T. and Kong, A.N. (2010) Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM. Carcinogenesis 31, 880-885 CrossRef PubMed
9. auf dem Keller, U., Huber, M., Beyer, T.A., Kumin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D.A., Johnson, J.A. et al. (2006) Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol. Cell Biol. 26, 3773-3784 CrossRef PubMed
10. Thimmulappa, R.K., Rangasamy, T., Alam, J. and Biswal, S. (2008) Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs. Med Chem. 4, 473-481 CrossRef PubMed
11. Wang, X.J., Sun, Z., Villeneuve, N.F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G.T., Wong, P.K. and Zhang, D.D. (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29, 1235-1243 CrossRef PubMed
12. Ren, D., Villeneuve, N.F., Jiang, T., Wu, T., Lau, A., Toppin, H.A. and Zhang, D.D. (2011) Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc. Natl. Acad. Sci. U.S.A. 108, 1433-1438 CrossRef PubMed
13. Singh, A., Misra, V., Thimmulappa, R.K., Lee, H., Ames, S., Hoque, M.O., Herman, J.G., Baylin, S.B., Sidransky, D., Gabrielson, E. et al. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420 CrossRef PubMed
14. Padmanabhan, B., Tong, K.I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.I., Kobayashi, A., Yokoyama, S. and Yamamoto, M. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell. 21, 689-700 CrossRef PubMed
15. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K. and Yamamoto, M. (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173, 154-160 CrossRef PubMed
16. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. and Yamamoto, M. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 24, 7130-7139 CrossRef PubMed
17. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J. and Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell Biol. 24, 10941-10953 CrossRef PubMed
18. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. and Hayes, J.D. (2006) Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281, 24756-24768 CrossRef PubMed
19. Tong, K.I., Kobayashi, A., Katsuoka, F. and Yamamoto, M. (2006) Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387, 1311-1320 CrossRef PubMed
20. Zhang, D.D. and Hannink, M. (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 23, 8137-8151 CrossRef PubMed
21. Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M. and Talalay, P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908-11913 CrossRef PubMed
22. McMahon, M., Lamont, D.J., Beattie, K.A. and Hayes, J.D. (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. U.S.A. 107, 18838-18843 CrossRef PubMed
23. Baird, L., Lleres, D., Swift, S. and Dinkova-Kostova, A.T. (2013) Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. U.S.A. 110, 15259-15264 CrossRef PubMed
24. Sun, Z., Wu, T., Zhao, F., Lau, A., Birch, C.M. and Zhang, D.D. (2011) KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response. Mol. Cell Biol. 31, 1800-1811 CrossRef PubMed
25. Sun, Z., Zhang, S., Chan, J.Y. and Zhang, D.D. (2007) Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 27, 6334-6349 CrossRef PubMed
26. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. and Hayes, J.D. (2004) Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279, 31556-31567 CrossRef PubMed
27. Rada, P., Rojo, A.I., Chowdhry, S., McMahon, M., Hayes, J.D. and Cuadrado, A. (2011) SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell Biol. 31, 1121-1133 CrossRef PubMed
28. Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A. and Hayes, J.D. (2013) Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32, 3765-3381 CrossRef PubMed
29. Wu, T., Zhao, F., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P.K., Chapman, E., Fang, D. and Zhang, D.D. (2014) Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev. 28, 708-722 CrossRef PubMed
30. Hetz, C. (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89-102 PubMed
31. Hast, B.E., Goldfarb, D., Mulvaney, K.M., Hast, M.A., Siesser, P.F., Yan, F., Hayes, D.N. and Major, M.B. (2013) Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res. 73, 2199-2210 CrossRef PubMed
32. Lau, A., Wang, X.J., Zhao, F., Villeneuve, N.F., Wu, T., Jiang, T., Sun, Z., White, E. and Zhang, D.D. (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell Biol. 30, 3275-3285 CrossRef PubMed
33. Lau, A., Zheng, Y., Tao, S., Wang, H., Whitman, S.A., White, E. and Zhang, D.D. (2013) Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner. Mol. Cell Biol. 33, 2436-2446 CrossRef PubMed
34. DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K.H., Yeo, C.J., Calhoun, E.S. et al. (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 CrossRef PubMed
35. Tao, S., Wang, S., Moghaddam, S.J., Ooi, A., Chapman, E., Wong, P.K. and Zhang, D.D. (2014) Oncogenic KRAS confers chemoresistance by upregulating NRF2. Cancer Res. 74, 7430-7441 CrossRef PubMed
36. Ramos-Gomez, M., Kwak, M.K., Dolan, P.M., Itoh, K., Yamamoto, M., Talalay, P. and Kensler, T.W. (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98, 3410-3415 CrossRef PubMed
37. Yates, M.S., Kwak, M.K., Egner, P.A., Groopman, J.D., Bodreddigari, S., Sutter, T.R., Baumgartner, K.J., Roebuck, B.D., Liby, K.T., Yore, M.M. et al. (2006) Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Res. 66, 2488-2494 CrossRef PubMed
38. Cleasby, A., Yon, J., Day, P.J., Richardson, C., Tickle, I.J., Williams, P.A., Callahan, J.F., Carr, R., Concha, N., Kerns, J.K. et al. (2014) Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PLoS One 9, e98896 CrossRef PubMed
39. Zhang, D.D. (2013) Bardoxolone brings Nrf2-based therapies to light. Antioxid. Redox Signal. 19, 517-518 CrossRef PubMed
40. Ellrichmann, G., Petrasch-Parwez, E., Lee, D.H., Reick, C., Arning, L., Saft, C., Gold, R. and Linker, R.A. (2011) Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease. PLoS One 6, e16172 CrossRef PubMed
41. Bomprezzi, R. (2015) Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther. Adv. Neurol. Disord. 8, 20-30 CrossRef PubMed
42. Rojo, A.I., Medina-Campos, O.N., Rada, P., Zuniga-Toala, A., Lopez-Gazcon, A., Espada, S., Pedraza-Chaverri, J. and Cuadrado, A. (2012) Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Free Radic. Biol. Med. 52, 473-487 CrossRef PubMed
43. Jiang, T., Chen, N., Zhao, F., Wang, X.J., Kong, B., Zheng, W. and Zhang, D.D. (2010) High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 70, 5486-5496 CrossRef PubMed
44. Shim, G.S., Manandhar, S., Shin, D.H., Kim, T.H. and Kwak, M.K. (2009) Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic. Biol. Med. 47, 1619-1631 CrossRef PubMed
45. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M. and Motohashi, H. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 22, 66-79 CrossRef PubMed
46. Ludtmann, M.H., Angelova, P.R., Zhang, Y., Abramov, A.Y. and Dinkova-Kostova, A.T. (2014) Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457, 415-424 CrossRef PubMed
47. Ooi, A., Wong, J.C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B.W., Tan, M.H., Zhang, Z., Yang, X.J. et al. (2011) An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 20, 511-523 CrossRef PubMed
48. Tong, K.I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T. and Yamamoto, M. (2006) Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell Biol. 26, 2887-2900 CrossRef PubMed
49. Muscarella, L.A., Parrella, P., D'Alessandro, V., la Torre, A., Barbano, R., Fontana, A., Tancredi, A., Guarnieri, V., Balsamo, T., Coco, M. et al. (2011) Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics 6, 710-719 CrossRef PubMed
50. Wang, R., An, J., Ji, F., Jiao, H., Sun, H. and Zhou, D. (2008) Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem. Biophys. Res. Commun. 373, 151-154 CrossRef PubMed